Top stories from the Proactive Investors UK newsroom.
Highlands Natural (LON:HNR) has entered into a two-year agreement to provide hemp-derived CBD to Cellulac, a company where AIM-listed Integumen (LON:SKIN) has a 9.35% stake. Highlands will supply Cellulac medical-grade CBD for use in Integumen's Labskin range of wound and skin care products.
Five-a-side league group Goals Soccer (LON:GOAL) has uncovered improper behaviour going back to 2010 that involves numerous individuals. Material uncertainty now exists over its historic figures and its latest accounts won’t now be ready in time to retain its listing on AIM.
RBS gave shareholders a mixed bag with its second quarter figures. Profits were well up at £1.6bn and there was a 12p special dividend but the bank says it is very unlikely the targets for 2020 will be met.